vimarsana.com
Home
Live Updates
Study results of psilocybin treatment in bipolar II depressi
Study results of psilocybin treatment in bipolar II depressi
Study results of psilocybin treatment in bipolar II depression published in JAMA Psychiatry
Believed to be first ever psilocybin clinical trial for treatment of bipolar II depressionLONDON, Dec. 06, 2023 -- Compass Pathways plc , a biotechnology company dedicated to accelerating patient...
Related Keywords
London ,
City Of ,
United Kingdom ,
Scott Aaronson ,
Sheppard Pratt ,
Stephen Schultz ,
Amy Lawrence ,
Meeting Of The American College Neuropsychopharmacology ,
Drug Administration ,
Exchange Commission ,
Linkedin ,
Nasdaq ,
Institute For Advanced Diagnostics ,
Annual Meeting ,
American College ,
Depression Rating Scale ,
Chief Science Officer ,
Advanced Diagnostics ,
Guy Goodwin ,
Chief Medical Officer ,
Compass Pathways ,
Breakthrough Therapy ,
Innovative Licensing ,
Access Pathway ,
Securities Act ,
Private Securities Litigation Reform Act ,